Stats
Affectis AG

Navigation

Title Filter 
1 Affectis Granted Patent for AFC-5128, other P2X7 Antagonists Wednesday, 25 January 2012
2 Affectis Pharmaceuticals and Merck Serono Announce an Agreement to Develop Oral Drugs for Neurodegenerative Diseases Wednesday, 08 June 2011
3 Affectis Pharmaceuticals Appoints Manfred Rüdiger as Chief Executive Officer Friday, 12 November 2010
4 Affectis Pharmaceuticals Raises €3.3M in Financing and Names Alex Martin Chief Executive Officer Monday, 22 March 2010
5 Affectis Pharmaceuticals AG Receives Research Grant from the State of Bavaria Technology Program Wednesday, 08 July 2009
6 Company Update – Affectis Pharmaceuticals strengthens its IP position Thursday, 02 April 2009
7 Affectis Pharmaceuticals and Mitsubishi Tanabe Pharma Enter Drug Discovery Collaboration Thursday, 02 April 2009
8 Affectis Pharmaceuticals AG Starts Phase II Clinical Trial with Cimicoxib for Depression Monday, 15 October 2007
9 Affectis Pharmaceuticals AG Announces Extension of Research Collaboration with Mitsubishi Pharma Monday, 05 March 2007
10 Dalton Pharma Services and Affectis Pharmaceuticals of Germany enter into a Contract Services Agreement Thursday, 01 March 2007
 
Page 1 of 3

Copyright © 2012 Affectis Pharmaceuticals AG. All Rights Reserved.